ESR1 and breast cancer: Thus, a potential isoform-based diagnosis in BC successfully combines WB/RPPA/IHC/IF and MS-based proteomics techniques that are used within the same experimental design to detect and quantify the isoforms of different proteins, such as estrogen receptor (ER) [22] or folate receptor (FR) [18].